- In July 2023, Smith & Nephew (U.K.) launched the REGENETEN Bioinductive Implant in India, a collagen-based implant designed for rotator cuff repair. This innovative implant promotes the growth of new tendon-such as tissue, improving the healing of damaged rotator cuffs. It reduces re-tear rates by 86% compared to traditional methods. The implant is inserted arthroscopically through a small incision and is gradually replaced by new tissue over six months. The launch is expected to address the growing rotator cuff repair market in India, with significant growth projected in the coming years
- In April 2023, 3M (U.S.) received FDA clearance for two Veraflo Therapy dressings: Veraflo Cleanse Choice Complete and V.A.C. Veraflo Cleanse Choice. These dressings are the first to be approved for hydromechanical removal of non-viable tissue, infectious materials, and wound debris. By reducing the need for surgical debridements, they promote faster wound healing and granulation tissue formation. This advancement enhances treatment efficiency and may lead to cost savings for healthcare systems. The approval underscores 3M's commitment to innovative wound care solutions
- In April 2025, Convatec (U.K.) received regulatory approval for ConvaNiox, the first nitric oxide-generating multimodal wound dressing. Designed to optimize the healing environment of diabetic foot ulcers (DFUs), ConvaNiox combines advanced dressing technology with the potent antimicrobial and antibiofilm properties of nitric oxide. Clinical trials have demonstrated that ConvaNiox reduces wound areas three times faster and increases DFU healing by 60% compared to standard care
